SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review - Dwinata, Michael; Putera, David; Hasan, Irsan; Raharjo, Monica (Clinical and Experimental Hepatology, 2020)